Eurofins · 5 days ago
Upstream Process Scientist - Ambr250 (Weekends)
Eurofins Scientific is an international life sciences company providing analytical testing services across multiple industries. They are seeking an Upstream Process Scientist to perform process development utilizing the Ambr250 system for large molecule products, support lab work, and ensure compliance with cGMP practices.
BiotechnologyGeneticsHealth CareLife SciencePharmaceutical
Responsibilities
Perform Upstream process development utilizing the Ambr250 Satorius system for large molecule based products within the API-Proteins group
Perform duties in a protocol-driven work, such as cell culture, and running Ambr bioreactors
Supporting lab work associated with development and scale-up projects within the API-Proteins area
Responsible for organizing records, capturing results into data sheets, and contributing to technical reports in a team environment as well as contributing individually to meet project timeline and objectives
Assist with general lab upkeep and organization efforts, which includes decontamination and disposal of large-scale cell culture/bioreactor wastes
Conduct, analysis and reporting of data in accordance with requirements set forth by the department
Record experimental data and accurate and highly organized laboratory notebooks
Comply with cGMP practices
Analyze and present data in professional format
Demonstrate clear and professional verbal and written communication
Follow appropriate SOPs and all internal documentation requirements
Qualification
Required
Bachelors or Master's degree in biopharmaceutical, biotechnology or pharmaceutical required
Broad knowledge in upstream process development and hands-on experience
Authorization to work in the United States indefinitely without restriction or sponsorship
Benefits
Comprehensive medical coverage
Dental
Vision options
Life and disability insurance
401(k) with company match
Paid vacation and holidays
Company
Eurofins
Eurofins provides testing and support services to the pharmaceutical, food, environmental, and consumer products industries.
Funding
Current Stage
Public CompanyTotal Funding
$1.05B2025-06-26Post Ipo Debt· $586.37M
2025-03-27Post Ipo Debt· $431.4M
2021-10-22Grant· $30M
Recent News
2025-12-16
Business Wire
2025-12-08
Company data provided by crunchbase